Earnings Ahead

REGN - Regeneron Pharmaceuticals

716.09 -68.29 -8.71

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

About

Profile

Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases.


Headquarters

Tarrytown, New York, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

REGN



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Regeneron stock dips amid decline in Eylea sales despite Q1 beat
  • Regeneron Pharmaceuticals Non-GAAP EPS of $10.09 beats by $0.53, revenue of $3.16B beats by $160M
  • Regeneron looks to strong Dupixent, Eylea sales in Q1 report
  • Regeneron Pharmaceuticals Q1 2023 Earnings Preview
  • Sanofi Q1 profit climbs on Dupixent as drug on track for €10B this year
  • Democratic senators introduce bill to enhance CMS drug price negotiations
  • Ghana 1st in world to approve new malaria vaccine by Oxford
  • U.S. launches $5B program to speed up development of next-gen COVID vaccines
  • Regeneron Pharmaceuticals Q1 one-off charges to be ~$56M
  • Regeneron Libtayo gets expanded approval in EU for lung cancer subtype
  • Amgen, AstraZeneca's asthma therapy Tezspire gets UK's NICE backing
  • Regeneron to pay Sonoma $75M upfront in pact to develop autoimmune disease drugs
  • Supreme Court hears arguments in Amgen Repatha patent case against Sanofi
  • Regeneron draws more bullish views from analysts after Dupixent COPD data
  • Regeneron up 7% following Dupixent data, Raymond James upgrade
  • Sanofi stock rises as Dupixent shows benefit in lung disease smokers, meets phase 3 goals
  • Regeneron gets FDA approval for expanded use of high cholesterol drug Evkeeza in kids
  • Sanofi and Regeneron's Dupixent gets approval in EU to treat eczema in kids over 6 months
  • Easing COVID pandemic sees many pharmas seeking alternate revenue streams
  • FDA accepts for review Regeneron/Sanofi's Dupixent application for inflammatory skin condition
Date Price Open High Low Vol Change ER
May 26, 2023 725.05 725
726.77
719
743K 0.01%
May 25, 2023 725 733.04
736.18
724.03
551K -1.68%
May 24, 2023 737.4 750.32
751.28
735.38
542K -1.49%
May 23, 2023 748.56 753.21
756.39
748.39
411K -0.39%
May 22, 2023 751.5 762.4
768.12
743.13
625K -0.99%
 
May 19, 2023 759.05 752.3
764.06
750.18
556K 1.55%
May 18, 2023 747.48 747.27
749.55
739.76
501K -0.29%
May 17, 2023 749.63 739.51
751.15
732.49
524K 0.99%
May 16, 2023 742.28 747.99
747.99
738.52
421K -1.16%
May 15, 2023 750.96 744.81
751.97
742.95
356K 0.89%
May 12, 2023 744.35 749.17
751.88
743.53
394K -0.16%
May 11, 2023 745.57 750.13
750.13
740.11
662K -0.54%
May 10, 2023 749.59 756.36
756.36
746.45
432K -0.7%
May 9, 2023 754.88 753.19
757.4
750.57
464K 0.37%
May 8, 2023 752.12 761.93
761.93
746.14
540K -1.31%
May 5, 2023 762.1 753.88
768.59
744.89
636K 1.09%
May 4, 2023 753.88 775.54
776.58
746.13
1.2M -6.14%
May 3, 2023 803.17 804.79
812.99
798.8
785K 0.59%
May 2, 2023 798.45 806.72
815.24
796.52
611K -1.03%
May 1, 2023 806.72 803.71
811.55
802.12
298K 0.61%
Apr 28, 2023 801.79 788.99
806.08
788
470K 1.20%
Apr 27, 2023 792.29 775.33
796.42
774.06
749K 1.84%
Apr 26, 2023 778 781.77
784.77
771.14
585K -1.47%
Apr 25, 2023 789.58 797.27
801.82
784.84
467K -0.94%
Apr 24, 2023 797.04 800.43
806.19
795.13
375K -0.46%
Apr 21, 2023 800.73 798.42
804.72
797.26
545K 0.33%
Apr 20, 2023 798.1 805.42
805.62
796.23
495K -1.33%
Apr 19, 2023 808.86 804.73
810.17
803.52
353K 0.11%
Apr 18, 2023 808.01 822.17
823.38
804.15
500K -1.43%
Apr 17, 2023 819.74 833.62
833.62
818.65
351K -1.16%
Apr 14, 2023 829.33 828.84
831.33
821.88
457K -0.12%
Apr 13, 2023 830.35 822.45
834.11
822.45
472K 1.21%
Apr 12, 2023 820.43 824.96
827.79
816.89
414K 0.10%
Apr 11, 2023 819.64 822.94
825.6
817.44
291K -0.5%
Apr 10, 2023 823.76 824.37
826.07
815.82
377K -0.6%
Apr 6, 2023 828.73 823.43
834
823.43
550K 0.43%
Apr 5, 2023 825.22 824.7
837.55
823.86
559K 0.38%
Apr 4, 2023 822.09 825.85
830.66
820.01
398K -0.5%
Apr 3, 2023 826.19 818.8
826.55
815.59
451K 0.55%
Mar 31, 2023 821.67 814.9
822.52
810.95
866K 1.25%
Mar 30, 2023 811.5 816.01
825.08
804.64
566K -0.96%
Mar 29, 2023 819.35 830
835
818.28
459K -0.92%
Mar 28, 2023 826.97 824
827.36
819.22
362K 0.80%
Mar 27, 2023 820.41 821.38
832.48
817.87
802K 0.05%
Mar 24, 2023 820 805.05
824
801.01
1.1M 2.22%
Mar 23, 2023 802.16 806.47
812.69
790.49
2.0M 6.77%
Mar 22, 2023 751.3 760.3
764.39
751.01
300K -1.11%
Mar 21, 2023 759.76 764.65
765.01
751.98
372K 0.07%
Mar 20, 2023 759.25 748.66
760.33
745.79
588K 1.55%
Mar 17, 2023 747.65 749.92
754.32
743.95
894K -0.28%
Mar 16, 2023 749.75 753.08
753.08
725.66
1.0M -1.39%
Mar 15, 2023 760.3 760.81
766.16
755
499K -0.85%
Mar 14, 2023 766.8 755.39
769.98
754.2
535K 1.92%
Mar 13, 2023 752.33 749.17
769.2
748.28
505K 0.71%
Mar 10, 2023 747 746.79
759.25
744.05
505K 0.44%
Mar 9, 2023 743.75 745.74
755.24
738.77
581K -0.19%
Mar 8, 2023 745.2 774.13
774.13
744
670K -3.7%
Mar 7, 2023 773.85 782
783.59
772.51
758K -0.84%
Mar 6, 2023 780.38 777.99
785.28
774.85
469K 0.14%
Mar 3, 2023 779.3 771.42
779.84
766.35
605K 0%